Patent ID: 8722856

Claim:
A MUC1-binding molecule, having at least one antigen-binding site comprising an immunoglobulin heavy chain variable region (VH) domain and an immunoglobulin light chain variable region (VL) domain, wherein the heavy chain variable region domain comprises CDR1, CDR2, and CDR3 sequences consisting of amino acid sequences NYGLS (SEQ ID NO.:4), ENHPGSGIIYHNEKFRG (SEQ ID NO.:5) and SSGTRGFAY (SEQ ID NO.:6), respectively, and the light chain variable region domain comprises CDR1′, CDR2′, and CDR3′ sequences consisting of sequences of RSSQSIVHSNGNTYLE (SEQ ID NO.:7), KVSNRFS (SEQ ID NO.:8) and FQGSHGPWT (SEQ ID NO.:9), respectively.